CN100525804C - 具有减肥作用的中药复方制剂 - Google Patents
具有减肥作用的中药复方制剂 Download PDFInfo
- Publication number
- CN100525804C CN100525804C CNB2006100282569A CN200610028256A CN100525804C CN 100525804 C CN100525804 C CN 100525804C CN B2006100282569 A CNB2006100282569 A CN B2006100282569A CN 200610028256 A CN200610028256 A CN 200610028256A CN 100525804 C CN100525804 C CN 100525804C
- Authority
- CN
- China
- Prior art keywords
- group
- fat
- animal
- liver
- weight
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 18
- 150000001875 compounds Chemical class 0.000 title claims abstract description 12
- 239000003814 drug Substances 0.000 title description 39
- 230000009471 action Effects 0.000 claims abstract description 7
- 241000195474 Sargassum Species 0.000 claims description 10
- 210000000582 semen Anatomy 0.000 claims description 10
- 239000000203 mixture Substances 0.000 claims description 7
- 230000003579 anti-obesity Effects 0.000 claims description 6
- -1 electuary Substances 0.000 claims description 3
- 239000000463 material Substances 0.000 claims description 3
- 239000002775 capsule Substances 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 15
- 238000012360 testing method Methods 0.000 abstract description 11
- 241001474374 Blennius Species 0.000 abstract 1
- 241000202726 Bupleurum Species 0.000 abstract 1
- 244000183685 Citrus aurantium Species 0.000 abstract 1
- 235000007716 Citrus aurantium Nutrition 0.000 abstract 1
- 244000088415 Raphanus sativus Species 0.000 abstract 1
- 235000006140 Raphanus sativus var sativus Nutrition 0.000 abstract 1
- 240000001341 Reynoutria japonica Species 0.000 abstract 1
- 235000018167 Reynoutria japonica Nutrition 0.000 abstract 1
- 241000304195 Salvia miltiorrhiza Species 0.000 abstract 1
- 235000011135 Salvia miltiorrhiza Nutrition 0.000 abstract 1
- 229930188824 alisol Natural products 0.000 abstract 1
- 241001465754 Metazoa Species 0.000 description 71
- 210000004185 liver Anatomy 0.000 description 34
- 230000037396 body weight Effects 0.000 description 33
- 235000019197 fats Nutrition 0.000 description 25
- 238000000034 method Methods 0.000 description 22
- 238000011282 treatment Methods 0.000 description 20
- 229940079593 drug Drugs 0.000 description 18
- 231100000240 steatosis hepatitis Toxicity 0.000 description 17
- 235000013305 food Nutrition 0.000 description 13
- 208000008589 Obesity Diseases 0.000 description 12
- 235000020824 obesity Nutrition 0.000 description 12
- 208000004930 Fatty Liver Diseases 0.000 description 11
- 206010019708 Hepatic steatosis Diseases 0.000 description 11
- 230000003203 everyday effect Effects 0.000 description 11
- 208000010706 fatty liver disease Diseases 0.000 description 11
- 235000009200 high fat diet Nutrition 0.000 description 10
- 241000699670 Mus sp. Species 0.000 description 9
- 239000000796 flavoring agent Substances 0.000 description 9
- 235000019634 flavors Nutrition 0.000 description 9
- 235000019786 weight gain Nutrition 0.000 description 8
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 7
- 210000000577 adipose tissue Anatomy 0.000 description 7
- 210000004369 blood Anatomy 0.000 description 7
- 239000008280 blood Substances 0.000 description 7
- 235000005911 diet Nutrition 0.000 description 7
- 239000000243 solution Substances 0.000 description 7
- 230000001225 therapeutic effect Effects 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- 230000004584 weight gain Effects 0.000 description 7
- 230000037213 diet Effects 0.000 description 6
- 238000007689 inspection Methods 0.000 description 6
- 230000001575 pathological effect Effects 0.000 description 6
- 230000007863 steatosis Effects 0.000 description 6
- 238000005303 weighing Methods 0.000 description 6
- 230000034994 death Effects 0.000 description 5
- 230000007850 degeneration Effects 0.000 description 5
- 238000002474 experimental method Methods 0.000 description 5
- 210000002966 serum Anatomy 0.000 description 5
- 239000006228 supernatant Substances 0.000 description 5
- 230000003442 weekly effect Effects 0.000 description 5
- 230000035568 catharsis Effects 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 230000013872 defecation Effects 0.000 description 4
- 238000001514 detection method Methods 0.000 description 4
- 239000000706 filtrate Substances 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 239000003292 glue Substances 0.000 description 4
- 210000003494 hepatocyte Anatomy 0.000 description 4
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 4
- 238000012856 packing Methods 0.000 description 4
- 230000009467 reduction Effects 0.000 description 4
- 210000001835 viscera Anatomy 0.000 description 4
- 230000006378 damage Effects 0.000 description 3
- 230000037308 hair color Effects 0.000 description 3
- 230000002440 hepatic effect Effects 0.000 description 3
- 230000002147 killing effect Effects 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 210000005228 liver tissue Anatomy 0.000 description 3
- 238000000386 microscopy Methods 0.000 description 3
- 238000012545 processing Methods 0.000 description 3
- 238000011084 recovery Methods 0.000 description 3
- 230000001603 reducing effect Effects 0.000 description 3
- 210000000952 spleen Anatomy 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 210000002784 stomach Anatomy 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- 238000001291 vacuum drying Methods 0.000 description 3
- 230000004580 weight loss Effects 0.000 description 3
- 235000019737 Animal fat Nutrition 0.000 description 2
- 102000004625 Aspartate Aminotransferases Human genes 0.000 description 2
- 108010003415 Aspartate Aminotransferases Proteins 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 2
- 206010020710 Hyperphagia Diseases 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- 102000004877 Insulin Human genes 0.000 description 2
- 108090001061 Insulin Proteins 0.000 description 2
- 206010028851 Necrosis Diseases 0.000 description 2
- 108090000279 Peptidyltransferases Proteins 0.000 description 2
- 101710098398 Probable alanine aminotransferase, mitochondrial Proteins 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 2
- 238000011047 acute toxicity test Methods 0.000 description 2
- 238000010171 animal model Methods 0.000 description 2
- 210000000436 anus Anatomy 0.000 description 2
- 230000036528 appetite Effects 0.000 description 2
- 235000019789 appetite Nutrition 0.000 description 2
- 235000021053 average weight gain Nutrition 0.000 description 2
- 238000004364 calculation method Methods 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- FPAFDBFIGPHWGO-UHFFFAOYSA-N dioxosilane;oxomagnesium;hydrate Chemical compound O.[Mg]=O.[Mg]=O.[Mg]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O FPAFDBFIGPHWGO-UHFFFAOYSA-N 0.000 description 2
- 238000004043 dyeing Methods 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 239000003172 expectorant agent Substances 0.000 description 2
- 230000003419 expectorant effect Effects 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 238000003304 gavage Methods 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 229940125396 insulin Drugs 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 150000002596 lactones Chemical class 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 210000005229 liver cell Anatomy 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 210000003470 mitochondria Anatomy 0.000 description 2
- 230000017074 necrotic cell death Effects 0.000 description 2
- 210000004279 orbit Anatomy 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 239000012188 paraffin wax Substances 0.000 description 2
- 231100000915 pathological change Toxicity 0.000 description 2
- 230000036285 pathological change Effects 0.000 description 2
- 230000007170 pathology Effects 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- 208000022530 polyphagia Diseases 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 230000009257 reactivity Effects 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 239000002689 soil Substances 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 2
- 239000002023 wood Substances 0.000 description 2
- 208000031648 Body Weight Changes Diseases 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- 208000035150 Hypercholesterolemia Diseases 0.000 description 1
- 206010060378 Hyperinsulinaemia Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010022998 Irritability Diseases 0.000 description 1
- 238000012449 Kunming mouse Methods 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 201000002451 Overnutrition Diseases 0.000 description 1
- 241000220317 Rosa Species 0.000 description 1
- 240000006394 Sorghum bicolor Species 0.000 description 1
- 235000007230 Sorghum bicolor Nutrition 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 231100000403 acute toxicity Toxicity 0.000 description 1
- 230000007059 acute toxicity Effects 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 238000012742 biochemical analysis Methods 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 230000004579 body weight change Effects 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 239000003610 charcoal Substances 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- WORJEOGGNQDSOE-UHFFFAOYSA-N chloroform;methanol Chemical compound OC.ClC(Cl)Cl WORJEOGGNQDSOE-UHFFFAOYSA-N 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 230000002354 daily effect Effects 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000006837 decompression Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000000151 deposition Methods 0.000 description 1
- 230000000994 depressogenic effect Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 235000020805 dietary restrictions Nutrition 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 231100000673 dose–response relationship Toxicity 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 239000003651 drinking water Substances 0.000 description 1
- 235000020188 drinking water Nutrition 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 210000001163 endosome Anatomy 0.000 description 1
- 210000000918 epididymis Anatomy 0.000 description 1
- 201000010063 epididymitis Diseases 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 230000005714 functional activity Effects 0.000 description 1
- 239000007952 growth promoter Substances 0.000 description 1
- 230000009931 harmful effect Effects 0.000 description 1
- 230000002443 hepatoprotective effect Effects 0.000 description 1
- 201000001421 hyperglycemia Diseases 0.000 description 1
- 230000003451 hyperinsulinaemic effect Effects 0.000 description 1
- 201000008980 hyperinsulinism Diseases 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000008595 infiltration Effects 0.000 description 1
- 238000001764 infiltration Methods 0.000 description 1
- 210000004969 inflammatory cell Anatomy 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 230000037230 mobility Effects 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 235000021590 normal diet Nutrition 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 235000020823 overnutrition Nutrition 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 210000004303 peritoneum Anatomy 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 206010036067 polydipsia Diseases 0.000 description 1
- 208000028280 polygenic inheritance Diseases 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000004064 recycling Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 238000009781 safety test method Methods 0.000 description 1
- 230000000405 serological effect Effects 0.000 description 1
- 235000002639 sodium chloride Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 210000001550 testis Anatomy 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 231100000041 toxicology testing Toxicity 0.000 description 1
- 229940126680 traditional chinese medicines Drugs 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 238000002054 transplantation Methods 0.000 description 1
- 210000003932 urinary bladder Anatomy 0.000 description 1
- 210000002229 urogenital system Anatomy 0.000 description 1
- 238000004804 winding Methods 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Description
组别 | 性别 | 数量 | 起始体重 | 结束体重 |
用药组 | ♂ | 10 | 18.89±0.76 | 32.33±2.01 |
♀ | 10 | 18.76±0.87 | 28.79±1.33 | |
对照组 | ♂ | 10 | 18.78±0.72 | 33.05±1.78 |
♀ | 10 | 18.23±0.46 | 29.47±2.35 |
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2006100282569A CN100525804C (zh) | 2006-06-28 | 2006-06-28 | 具有减肥作用的中药复方制剂 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2006100282569A CN100525804C (zh) | 2006-06-28 | 2006-06-28 | 具有减肥作用的中药复方制剂 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101095767A CN101095767A (zh) | 2008-01-02 |
CN100525804C true CN100525804C (zh) | 2009-08-12 |
Family
ID=39009988
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB2006100282569A Expired - Fee Related CN100525804C (zh) | 2006-06-28 | 2006-06-28 | 具有减肥作用的中药复方制剂 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN100525804C (zh) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103721110A (zh) * | 2014-01-23 | 2014-04-16 | 邹宏 | 具有保健减肥功效的中药配方及其制备方法 |
CN107714997A (zh) * | 2017-11-10 | 2018-02-23 | 山西康逸堂生物科技有限公司 | 一种减肥中药及其制作方法 |
-
2006
- 2006-06-28 CN CNB2006100282569A patent/CN100525804C/zh not_active Expired - Fee Related
Non-Patent Citations (4)
Title |
---|
肥胖机制及中医药防治肥胖症的研究进展. 李松,邹旭,邓铁涛.中西医结合心脑血管病杂志,第2卷第11期. 2004 |
肥胖机制及中医药防治肥胖症的研究进展. 李松,邹旭,邓铁涛.中西医结合心脑血管病杂志,第2卷第11期. 2004 * |
近10年中医药治疗单纯性肥胖临床研究概况. 杨春壮,郑海兴.中医药信息,第22卷第6期. 2005 |
近10年中医药治疗单纯性肥胖临床研究概况. 杨春壮,郑海兴.中医药信息,第22卷第6期. 2005 * |
Also Published As
Publication number | Publication date |
---|---|
CN101095767A (zh) | 2008-01-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102048933B (zh) | 一种治疗小儿腹泻的中药组合物及其制备方法 | |
CN101884684B (zh) | 基于治未病和药食同源理论的防治便秘的食疗制剂 | |
CN103301413A (zh) | 一种治疗高血脂合并高血糖症的中药组合物 | |
CN107912773A (zh) | 一种用于缓解体力疲劳的制剂 | |
CN104206595A (zh) | 一种降脂降糖的地骨皮保健茶及其制备方法 | |
CN103041262B (zh) | 一种治疗慢性前列腺炎的中药灌肠剂及其制备方法 | |
CN100525804C (zh) | 具有减肥作用的中药复方制剂 | |
CN103908611A (zh) | 一种治疗结肠癌的中药制剂及其制备方法 | |
CN105211441A (zh) | 一种降压降脂的丹参叶保健茶及其制备方法 | |
CN104286864A (zh) | 一种提高免疫力的沙苑子口服液及其制备方法 | |
CN1430982A (zh) | 芪蜂胶囊及其制备工艺 | |
CN103272146B (zh) | 一种防治酒精性脂肪肝的药物组合物及制备方法 | |
CN102293855A (zh) | 治疗脾肾两虚型糖尿病肾病的中药组合物及其制备方法与应用 | |
CN102698206B (zh) | 一种治疗非酒精性脂肪肝的中药及其制备方法 | |
CN104162090B (zh) | 一种药物组合物及其制备方法 | |
CN103751692B (zh) | 一种海狗鞭特补胶囊及其制备方法 | |
CN107638493A (zh) | 治疗消化不良的药物组合物及其制备方法和用途 | |
CN108186821A (zh) | 一种治疗神经性头痛的中药组合物及其制备方法和用途 | |
TWI440465B (zh) | 用以降血脂的中草藥萃取混合物及其醫藥組合物 | |
CN109731087A (zh) | 一种解酒益肾的中药组合物及应用 | |
CN101884690B (zh) | 基于治未病和药食同源理论的排毒养颜食疗制剂 | |
CN109463749A (zh) | 一种缓解经期疼痛的中药保健食品 | |
CN102579713A (zh) | 治疗儿童肥胖症的中药及制备方法 | |
CN112138110A (zh) | 一种“逍遥酥”复合制剂的制备方法及其在制备预防或治疗疲劳的药物中的应用 | |
CN100336555C (zh) | 一种抗肿瘤的参丹胶囊及其制备工艺 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: SHANGHAI HUAZHI NATURAL MEDICINE TECHNOLOGY DEVELO Free format text: FORMER OWNER: LIU ZHIHUA Effective date: 20110221 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 200135 ROOM 1503, NO. 10, LANE 999, DINGXIANG ROAD, PUDONG NEW DISTRICT, SHANGHAI TO: 200137 2/F, BUILDING 2, NO. 399, XINGNAN ROAD, PUDONG NEW DISTRICT, SHANGHAI |
|
TR01 | Transfer of patent right |
Effective date of registration: 20110221 Address after: Two building 2, building 399, 200137 South Road, Shanghai, Pudong New Area Patentee after: Shanghai Huazhi natural medicine science and Technology Development Co.,Ltd. Address before: 200135, room 10, No. 999, Lane 1503, Dingxiang Road, Shanghai, Pudong New Area Patentee before: Liu Zhihua |
|
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20090812 |